Patient Satisfaction with Prenatal Telegenetic Counseling Performed in Two Different Settings

Patterns of Disease in Patients with Primary Biliary Cholangitis across the United States: The Labcorp Experience

Labcorp to speak at UBS Global Healthcare virtual conference

BURLINGTON, N.C. --(BUSINESS WIRE)--May 18, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at the UBS Global Healthcare Virtual Conference on Monday, May 24 at 3:00 p.m.

Pixel by Labcorp COVID-19 PCR test home collection kit receives FDA Emergency Authorization for ages 2-17

BURLINGTON, N.C. --(BUSINESS WIRE)--May 13, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Pixel by Labcorp COVID-19 PCR Test Home Collection Kit for ages 2-17. The authorization expands the use of Pixel by Labcorp to children and adolescents 2 years of age and older when purchased by a parent or guardian.

Labcorp prices $500,000,000 in 1.550% Senior Notes due 2026 and $500,000,000 in 2.700% Senior Notes due 2031

BURLINGTON, N.C. --(BUSINESS WIRE)--May 12, 2021-- Labcorp (NYSE: LH) (“Labcorp”) announced today that it has priced its offering of $1,000,000,000 in Senior Notes.